Cardiol Therapeutics: HC Wainwright Raises PT to $9, Maintains Buy Rating.

lunes, 1 de diciembre de 2025, 1:16 pm ET1 min de lectura
CRDL--

Cardiol Therapeutics: HC Wainwright Raises PT to $9, Maintains Buy Rating.

Cardiol Therapeutics: HC Wainwright Raises PT to $9, Maintains Buy Rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios